Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1655 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Orexigen Therapeutics Names New Board Of Director

Dr Dixon brings 30 years of pharmaceutical development and commercial experience to the Orexigen board. His experience includes commercialisation strategy, new product launches and portfolio evaluation in cardiometabolic

Novartis Gets FDA Approval For Zortress

Zortress is to be given in combination with reduced doses of the calcineurin inhibitor (CNI) cyclosporine, as well as basiliximab and corticosteroids. The active ingredient in Zortress is

Bayer HealthCare Appoints New CEO

Reportedly, the current CEO of Bayer HealthCare, Arthur Higgins, is expected to leave the company on April 30, 2010 . Werner Wenning, chairman of the board of management